Anzeige
Mehr »
Login
Freitag, 25.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Jetzt knallt's an der Börse! Diese Aktie hat das Zeug zum Überflieger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoRoche's Genentech enters $765m autoimmune disease partnership with Repertoire
DoBiogen's Skyclarys granted MHRA approval for rare movement disorder Friedreich's ataxia
DoGilead shares promising phase 3 results for Trodelvy plus Keytruda in aggressive breast cancer
DoDE&I - don't throw the baby out with the bathwater
MiPfizer's Hympavzi granted MHRA approval to treat haemophilia A and B
MiBMS receives NICE recommendation for immunotherapy combination in colorectal cancer
MiAstraZeneca/Daiichi Sankyo's Enhertu shows promise in first-line HER2-positive breast cancer
MiTackling the antibiotic resistance crisis
DiUnlock the Future of Patient Recruitment: Learnings from 15 Years of Innovation
DiSanofi/Regeneron's Dupixent granted FDA approval for chronic spontaneous urticaria
DiGSK's Blenrep combinations approved by MHRA to treat multiple myeloma
DiFDA approves pre-filled syringe version of argenx's immune disorder drug Vyvgart
DiCoach Tolstoy: The surprising coaching lesson from Russian literature
17.04.GSK's five-in-one meningococcal vaccine recommended by CDC advisory committee
17.04.LEO Pharma and the Parker Institute join forces to advance dermatology research
17.04.FDA grants interchangeable designation to Celltrion's Humira biosimilar Yuflyma
17.04.The impact of multiple sclerosis on ageing patients
16.04.Shared decision-making in oncology - turning principles into practice
16.04.Biogen/Eisai's Alzheimer's disease drug Leqembi granted EC approval
16.04.Merck and Cyprumed enter oral peptide partnership worth over $493m
16.04.Boehringer and Cue partner to advance autoimmune disease candidate in deal worth $357m
16.04.Reducing disparities in healthcare through shared decision-making
15.04.NHS programme to give melanoma patients fast-track access to skin cancer vaccine
15.04.J&J's subcutaneous Darzalex regimen approved by EC for newly diagnosed multiple myeloma
15.04.Amgen shares positive phase 3 results for Imdelltra in small cell lung cancer